MDACC Study Summary 2006-0744

Study Summary
No. 2006-0744:.......Other Studies......Maria Suarez-Almazor......General Internal Medicine/Ambulatory Treatment & Emergency Care

Study Summary Title



Study Summary Number:	2006-0744

Study Title:	Applying Social Marketing Techniques to Improve Therapeutics Adherenece in Patients with Human Immunodeficiency Virus

Physician

New Patient Referral



Name:	Maria Suarez-Almazor	Patients Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Dept:	General Internal Medicine/Ambulatory Treatment & Emergency Care	Referring MD Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Phone:	713-745-8328 Contact us about clinical trials

General Information



Disease Group:	Other Studies	Supported By:	N/A

Phase of Study:	Phase II	Return Visit:	No diagnostic tests, treatments, or psychological tests will be conducted on any UTMDACC patients.NA

Treatment Agents:	None	Home Care:	No diagnostic tests, treatments, or psychological tests will be conducted on any UTMDACC patients.NA

Treatment Loc:	Independent Multicenter Arrangements

Estimated Length of Stay in Houston:	No diagnostic tests, treatments, or psychological tests will be conducted on any UTMDACC patients. NA


Description/ Intervention:	Unavailable

Study Objectives / Outcomes

Baylor College of Medicine has a subcontract with UTMDACC to recruit and enroll patients for this pilot study. All data collection will be completed at Baylor/Thomas Street Clinic and Thomas Street Pharmacy in accordance with BCM IRB. The role of Dr. Suarez-Alamzor and UTMDACC staff will be to evaluate the data after it is collected. All patients will be informed as part of informed consent that de-identified data and their private health information (also de-identified) will be analyzed at UTMDACC under the direction of Dr. Suarez-Almazor and her research staff.
Objective 1: To assess qualitative data collected by Baylor College of Medicine through focus groups. The information from this evaluation will be used to develop a social marketing intervention to improve adherence to highly active anti-retroviral treatment (HAART) among HIV patients at the Thomas Street Clinic. Dr. Suarez-Almazor will receive the data from the BCM research team and will conduct a qualitative analysis.
Objective 2: To test the impact of the intervention on adherence to HAART. Dr. Suarez-Almazor will use data collected by the BCM research team and provided by the Thomas Street Pharmacy to evaluate the efficacy of the social marketing intervention. Refill data for 6-months pre-intervention and 6-month post-intervention for all patients (approximately 2000) utilizing the Thomas Street Pharmacy that filled at least one presciption will be evaluated. Data will be de-identified prior to transfer to UTMDACC. To further test the efficacy of the intervention, self-report HAART adherence data from 500 patients (collected by BCM investigators) will be analyzed by Dr. Suarez-Almazor and her research team.

Study Status Information



Study Activation / Registration Date:

IRB Review and Approval Date:	05/15/2009

Study Type:	Behavioral

Recruitment Status:	Open

Projected Accrual:	2570

Enrollment Eligibility

If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.

Inclusion Criteria:

1) No UTMDACC patients will be enrolled in this study.

Exclusion Criteria:

1) No UTMDACC patients included in study.

Links

Registration Number: Not Applicable Clinical Trial